Result of Voting for Directors at Annual Shareholders’ Meeting
Tweet
Share
E-mailTORONTO, April 11, 2025 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (TSX: FFH and FFH.U) (“Fairfax”) is pleased to announce the results of the vote on Directors at its April 10, 2025 Annual Shareholders’ Meeting.
Each of the nominee directors listed in Fairfax’s management proxy circular dated March 7, 2025 was elected as a director. The voting results for the twelve directors nominated for election are set forth in the table below:
| Name of Nominee | Vote For (Aggregate) | % | Vote Against (Aggregate) | % | Vote For (Subordinate Voting Shares) | % | Vote Against (Subordinate Voting Shares) | % | |
| Robert J. Gunn | 27,865,053 | 95.18 | 1,410,143 | 4.82 | 11,495,427 | 89.07 | 1,410,143 | 10.93 | |
| David L. Johnston | 28,997,648 | 99.05 | 277,551 | 0.95 | % | 12,628,022 | 97.85 | 277,551 | 2.15 |
| Karen L. Jurjevich | 28,603,796 | 97.71 | 671,400 | 2.29 | 12,234,170 | 94.80 | 671,400 | 5.20 | |
| Christine A. Magee | 29,132,616 | 99.51 | 142,583 | 0.49 | % | 12,762,990 | 98.90 | 142,583 | 1.10 |
| R. William McFarland | 27,562,516 | 94.15 | 1,712,684 | 5.85 | 11,192,890 | 86.73 | 1,712,684 | 13.27 | |
| Christine N. McLean | 28,967,761 | 98.95 | 307,438 | 1.05 | 12,598,135 | 97.62 | 307,438 | 2.38 | |
| Brian J. Porter | 29,113,736 | 99.45 | 161,464 | 0.55 | 12,744,110 | 98.75 | 161,464 | 1.25 | |
| Timothy R. Price | 28,214,644 | 96.38 | 1,060,552 | 3.62 | 11,845,018 | 91.78 | 1,060,552 | 8.22 | |
| Lauren C. Templeton | 29,114,920 | 99.45 | 160,279 | 0.55 | 12,745,294 | 98.76 | 160,279 | 1.24 | |
| Benjamin P. Watsa | 28,959,465 | 98.92 | 315,735 | 1.08 | 12,589,839 | 97.55 | 315,735 | 2.45 | |
| V. Prem Watsa | 27,576,707 | 94.20 | 1,698,479 | 5.80 | 11,207,081 | 86.84 | 1,698,479 | 13.16 | |
| William C. Weldon | 26,809,775 | 91.58 | 2,465,422 | 8.42 | 10,440,149 | 80.90 | 2,465,422 | 19.10 | |
Fairfax is a holding company which, through its subsidiaries, is primarily engaged in property and casualty insurance and reinsurance and the associated investment management.
| For further information contact: | John Varnell, Vice President, Corporate Development, at (416) 367-4941 |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate
- HTX Research Examines U.S. AI Equities: Technology Remains Early, While Capital Expenditure and Valuations Have Entered the Late Cycle
- Airworthy.com Releases 2026 State of General Aviation Parts Report
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
